Theodore James Jr. Washburn - 01 Mar 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Principal Accounting Officer
Signature: /s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Issuer symbol: AGIO
Transactions as of: 01 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2022, 15:10:20 UTC
Previous filing: 01 Mar 2022
Next filing: 14 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Award	$0	+2,331		$0.000000	2,331	01 Mar 2022	Common stock	2,331		Direct	F1, F2
transaction	AGIO	Stock options (right to buy)	Award	$0	+1,165		$0.000000	1,165	01 Mar 2022	Common stock	1,165	$32.20	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2	The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
F3	This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.